Background
==========

Peripheral artery disease (PAD), a common manifestation of atherosclerosis in the lower limbs, causes significant morbidity and mortality in the United States \[[@B1]-[@B4]\]. Atherosclerotic plaques tend to develop at branch points in the peripheral arteries, increasing vascular resistance and limiting blood flow in the affected arteries \[[@B5]\]. Baseline blood flow to skeletal muscle is generally maintained through the recruitment of collateral arteries \[[@B5],[@B6]\], however the vasculature is unable to quickly respond to changes in metabolic demand, such as those that occur with exercise or following a period of ischemia. Analogous to cardiac stress testing, the functional integrity of the peripheral vasculature can be interrogated by measuring the dynamic response to a period of induced ischemia.

Skeletal muscle can be stressed by means of an ischemia-reperfusion paradigm, which induces reactive hyperemia. Suprasystolic pressure applied by a cuff secured around the thigh halts distal blood flow for several minutes. Oxygen extraction in the stagnant capillary blood continues until it reaches a steady state, approximately 140 seconds into the period of arterial occlusion \[[@B7]\]. When pressure in the cuff is released, reactive hyperemia ensues with a surge in arterial flow resulting in an increase in perfusion \[[@B8]\] and oxygen concentration at the level of the capillary bed \[[@B7],[@B9]\]. Additionally, venous oxygen saturation (SvO~2~) within the large draining veins sharply decreases as the desaturated blood formerly trapped in the capillary bed enters. As the tissue oxygenation recovers, SvO~2~ rises and eventually surpasses its baseline value during the time that oxygen delivery exceeds the oxygen extraction rate \[[@B10]\], or during which time physiologic shunting may be occurring.

Several magnetic resonance (MR) techniques can non-invasively evaluate the hyperemic response. Arterial spin labeling (ASL) is a well-known method to investigate perfusion in many vascular territories \[[@B11]-[@B16]\]. Skeletal muscle perfusion is an important parameter that quantifies microvascular blood flow thereby providing information on delivery of oxygen and nutrients to tissue. It has been shown that perfusion dynamics during reactive hyperemia are altered in PAD \[[@B17]\]. These findings correlate with both disease presence and severity.

A relative measure of tissue oxygenation can be obtained by measuring changes in the apparent transverse relaxation rate (T~2~\*), also known as 'blood oxygen-level dependent' (BOLD) signal \[[@B18]\]. T~2~\* can be measured using a multi-echo gradient-recalled echo (GRE) sequence. BOLD imaging has been extensively applied for functional activation studies in the brain \[[@B19]\], and can also provide information regarding activation and oxygenation of many other tissues including the kidneys \[[@B20]\] and skeletal muscle \[[@B7],[@B8],[@B21]-[@B23]\].

Dynamic measurement of SvO~2~ provides information about oxygen utilization in tissue. When continuously measured throughout an ischemia-reperfusion paradigm, intravascular blood can act as an endogenous tracer, allowing SvO~2~ time-course kinetics to provide information on endothelial function and vascular reactivity \[[@B10]\]. SvO~2~ can be dynamically measured using MR susceptometry \[[@B24]\]. Each of the aforementioned MR methods will be discussed in detail in the Theory section.

The kinetics of the hyperemic response can provide information on microvascular integrity and endothelial function. Healthy subjects are able to rapidly respond to increases in oxygen demand, and recover back to baseline more quickly than patients with PAD \[[@B17],[@B25],[@B26]\]. While methods for simultaneous quantification of perfusion and T~2~\* or other markers of tissue oxygenation have been implemented \[[@B27],[@B28]\], none have been able to investigate SvO~2~ time-course kinetics as well. Recovery dynamics are altered in each of these parameters in situations of impaired vascular function, as in PAD; therefore there is potentially added benefit to concurrent measurement. In this work, we developed a method to measure perfusion, SvO~2~, and T~2~\* simultaneously. Such a technique allows for a full functional assessment of the peripheral vasculature during a single scan providing information on the temporal relationships between these various functional parameters.

Theory
======

Pulsed arterial spin labeling perfusion imaging
-----------------------------------------------

Pulsed arterial spin labeling (PASL) MRI is a well-established method for noninvasive perfusion imaging \[[@B13],[@B14],[@B29]\]. In one PASL variant developed by Raynaud, et al. \[[@B16]\], termed Saturation Inversion Recovery (SATIR), slice-selective (SS) and non-selective (NS) inversion pulses are applied for the tag and control images, respectively. Every acquisition is followed by a slice-selective saturation pulse to ensure the same initial magnetization in each dynamic image.

The normalized difference between the tag and control images can be used to quantify perfusion in physiologic units of milliliters of blood, per minute, per 100 grams of tissue, as described in \[[@B16]\]. The resulting Bloch equations can be solved analytically for perfusion (f) if the longitudinal relaxation times (T~1~) of arterial blood and tissue are assumed to be equal:

$$f = - \frac{\lambda}{T} \cdot \ln\left\lbrack {\frac{M_{SS}\left( T \right) - M_{NS}\left( T \right)}{M_{SS}\left( T \right) + M_{NS}\left( T \right)} \cdot \left( {1 - e^{\frac{T}{T_{1}}}} \right) + 1} \right\rbrack$$

where M~SS~ and M~NS~ are the signal intensities (SI) in the image acquired after SS and NS inversion, respectively, λ is the tissue partition coefficient (0.9 mL/g), and T is the post-labeling delay (PLD), defined as the time between the inversion pulse and readout. At 3T, T~1blood~ = 1664 ms \[[@B30]\] and T~1tissue~ = 1420 ms \[[@B31]\]. A numerical calculation based on actual values for blood and tissue T~1~ shows that for perfusion values up to 100 mL/min/100g, using T~1tissue~ ≈ T~1blood~ = 1420 ms, underestimates perfusion by less than 5%.

SATIR has been successfully applied for perfusion imaging in the leg in healthy individuals \[[@B16]\], and the sequence has been employed to simultaneously measure BOLD \[[@B28],[@B32]\], however it has not been integrated with a multi-echo GRE for venous oxygen saturation and BOLD measurements.

MR susceptometry-based dynamic oximetry
---------------------------------------

MR susceptometry-based oximetry is a recently developed method for quantifying SvO~2~, measured in units of percent-oxygenated hemoglobin (%HbO~2~) \[[@B10],[@B24],[@B33],[@B34]\]. Because deoxyhemoglobin is paramagnetic, a magnetic susceptibility difference exists between deoxygenated blood and oxygenated blood or tissue. This susceptibility difference induces a local magnetic field ∆*B* in the draining vein relative to the tissue, proportional to (1- SvO~2~/100). The incremental field ∆*B* can be determined by subtracting the phase accumulation of the MR signal in surrounding tissue from that inside the vein (∆*φ*). The phase is measured from successive echoes separated in echo time by ΔTE. By modeling the vein as a long paramagnetic cylinder it is possible to quantify intravascular SvO~2~ as:

$$\mathit{Sv}O_{2} = \left\lbrack {1 - \frac{2\left( \frac{\left| {\Delta\varphi} \right|}{\Delta TE} \right)}{\gamma\ \Delta\chi_{\mathit{do}} \cdot {Hct} \cdot B_{0}\left( {\cos^{2}\theta - \frac{1}{3}} \right)}} \right\rbrack \times 100\ $$

where Δχ~*do*~ represents the susceptibility difference between fully oxygenated and fully deoxygenated blood (Δχ~*do*~ = 4π•0.27 ppm (SI units) \[[@B35],[@B36]\]), B~0~ is the main magnetic field strength, and θ is the angle of the vessel with respect to B~0~\[[@B24],[@B33]\]. It has been shown that for small angles, the induced field outside of the vessel is approximately homogeneous and independent of the susceptibility difference between the vein and tissue \[[@B37]\]. Therefore SvO~2~ can be measured using a field-mapping sequence, such as a multi-echo GRE. With this technique, one can quickly, directly, and noninvasively quantify intravascular SvO~2~ at high-temporal resolution.

Skeletal muscle BOLD
--------------------

In the microvasculature, as in the large veins, the paramagnetism of deoxyhemoglobin causes inhomogeneities in the local magnetic field. Because the microvessels are so small, it is not possible to directly measure the change in phase signal as is required for susceptometry-based oximetry. However, this local field perturbation also results in intravoxel phase dispersion, which causes the MR signal to decay more rapidly \[[@B18]\]. For instance, as oxygen saturation in the capillary bed decreases, the concentration of deoxygenated hemoglobin increases, resulting in an increased intravoxel phase dispersion thereby lowering the apparent transverse relaxation time, T~2~\*. Thus changes in T~2~\* in response to an ischemia-reperfusion paradigm can serve as a relative marker of tissue oxygenation \[[@B7]\]. The BOLD signal originates not only from changes in blood oxygen level, it is also sensitive to changes in perfusion, cellular pH, vessel diameter, and vessel orientation \[[@B9],[@B21],[@B23],[@B38]-[@B40]\]. It has been postulated, however, that the BOLD signal changes primarily result from changes in the concentration of deoxyhemoglobin in the capillary bed \[[@B40]\]. Quantification of T~2~\* can be achieved by fitting signal intensity data from a multi-echo GRE to a monoexponential function. Prior studies have shown the utility of investigating dynamic skeletal muscle BOLD during exercise \[[@B41]-[@B43]\], ischemia \[[@B38]\], reactive hyperemia \[[@B8]\], and in disease states \[[@B26],[@B44]\].

Simultaneous measurement of perfusion, SvO~2~, and T~2~\*
---------------------------------------------------------

By interleaving a multi-echo GRE sequence in the PLD of a PASL sequence, perfusion, SvO~2~, and T~2~\* can be concurrently measured. From multi-echo GRE data, the difference in signal phase between venous blood and surrounding tissue yields SvO~2~, while fitting the amplitude of the same data to a monoexponential function yields T~2~\*. The sequence, termed Perfusion, Intravascular Venous Oxygen saturation, and T~2~\* (PIVOT), makes use of the PLD dead time inherent to all PASL sequences to acquire SvO~2~ and T~2~\* data at a separate slice location with a multi-echo GRE (Figure [1](#F1){ref-type="fig"}). This allows dynamic quantification of perfusion, SvO~2~, and T~2~\* within a single scan.

![**Pulse sequence diagram of PIVOT.** A slice-selective (shown by SS only gradient) or non-selective adiabatic inversion pulse labels blood for perfusion imaging. During the PLD a keyhole multi-echo GRE acquires data downstream from the perfusion slice location for SvO~2~ (blue) and T~2~\* (green) analysis. An EPI readout at isocenter (red) is used to acquire the images for perfusion quantification.](1532-429X-15-70-1){#F1}

In PIVOT, as in SATIR, tag and control conditions for perfusion imaging are achieved using SS and NS inversion pulses, respectively. During the PLD, a keyhole \[[@B45]\] multi-echo GRE sequence acquires data at a distal slice for SvO~2~ and T~2~\* quantification. The distal location was chosen to ensure that the multi-echo GRE interleave does not impact the signal from previously labeled perfusing blood. Because the NS inversion affects both the PASL and multi-echo GRE slices, only multi-echo GRE data acquired following SS inversion are analyzed, though the interleave is run every PLD to control for magnetization transfer effects. The multi-echo GRE is immediately followed by a GRE-EPI readout at isocenter to capture data for perfusion quantification.

Methods
=======

Study design
------------

The University of Pennsylvania's Institutional Review Board approved all imaging procedures, and each subject provided informed consent prior to his or her participation. To evaluate PIVOT compared to the standard measurement methods, five young healthy male subjects (27 ± 2 years old) were recruited and imaged on two separate occasions (Visit 1 and Visit 2). Four ten-minute scans were run in both sessions, each scan consisting of one minute baseline, three minute arterial occlusion, and six minute recovery. PIVOT, a repeat of the PIVOT scan (PIVOT Repeat), an otherwise identical PASL-only sequence, or otherwise identical multi-echo GRE-only sequence were run in a randomized order. To ensure the PASL interleave did not impact quantification of SvO~2~ and T~2~\*, dynamic SvO~2~ and T~2~\* results obtained with PIVOT were compared to the multi-echo GRE-only derived SvO~2~ and T~2~\* results. Similarly, to ensure the multi-echo GRE interleave did not confound perfusion, the perfusion results obtained with PIVOT were compared to the PASL-only derived perfusion data. PIVOT was repeated to provide data on the intra-session variability of these parameters.

In addition, five PAD patients (67.2 ± 6.8 years old, ankle-brachial index (ABI) = 0.61 ± 0.14, 3 male) were drawn from an ongoing study and PIVOT imaging was performed during a single ischemia-reperfusion paradigm. For experiments in PAD patients, the total scan time was 12 minutes, with 2 minutes of baseline, 5 minutes of arterial occlusion, and 6 minutes of recovery. Since repeated arterial occlusions were not performed in PAD patients, a longer ischemic duration was used to ensure a maximal hyperemic response.

Imaging
-------

PIVOT, PASL-only, and multi-echo GRE-only sequences were written in SequenceTree \[[@B46]\] and exported for use on a 3T scanner (Siemens Medical Equipment; Erlanger, Germany). Each subject was positioned with the maximum girth of the calf centered in an 8-channel transmit/receive knee coil (Invivo, Inc; Gainesville, FL). For proximal arterial occlusion, a cuff was secured around the thigh and was rapidly inflated to 75 mmHg above the systolic pressure using the Hokanson E20 AG101 Rapid Cuff Inflation System (D. E. Hokanson, Inc; Bellevue, WA). Perfusion images were acquired with a partial Fourier GRE-EPI readout with the following parameters: FOV = 250 × 250 mm^2^; acquired matrix = 80×50, reconstructed to 80 × 80; slice thickness = 1 cm; slice location = isocenter; TR/TE = 1 s/8.05 ms; PLD = 952 ms. The keyhole multi-echo GRE used the following parameters: FOV = 96 × 96 mm^2^; keyhole acquired matrix = 96 × 24, (for SvO~2~ data analysis, reconstructed matrix = 96 × 96 using a fully sampled reference image obtained immediately after the dynamic PIVOT or multi-echo GRE acquisition; only dynamic data were used for T~2~\* analysis); slice thickness = 1 cm; slice location = 3 cm inferior from isocenter; TR/TE~1~/TE~2~/TE~3~/TE~4~/TE~5~ = 38.12/3.78/6.99/12.32/19.32/26.32 ms. Perfusion, SvO~2~, and T~2~\* each were quantified with two-second temporal resolution.

Data analysis
-------------

*Perfusion*: Perfusion was measured in the soleus muscle. High spatial-resolution scout images were used as a reference, and a region of interest (ROI) in the soleus was visually selected on the EPI images. As the GRE-EPI data are inherently T~2~\*-weighted, SI variation occurred throughout the ischemia-reperfusion paradigm due to the BOLD effect. Direct subtraction between adjacent NS and SS images would yield data with a mixture of perfusion, and ΔT~2~\*-weighting. To account for this potential confound, NS time-series data were linearly interpolated to temporally match the SS time-course prior to perfusion quantification \[[@B47]\]. Perfusion was calculated using Equation 1 \[[@B16]\]. In order to correct for baseline perfusion offset, the average perfusion during the period of arterial occlusion was calculated and subtracted from each time-point as described in \[[@B47]\]. Peak hyperemic flow (PHF), time to peak (TTP), hyperemic flow volume (HFV), and hyperemic duration were measured (Figure [2](#F2){ref-type="fig"}a).

![**Schematic of time-course for perfusion (a), SvO**~**2**~**(b), and T**~**2**~**\* (c) illustrating the time**-**course**-**derived metrics for each parameter.** Grey box indicates the period of proximal arterial occlusion.](1532-429X-15-70-2){#F2}

*Oximetry*: Dynamic SvO~2~ images were reconstructed to a matrix size of 96 × 96 using outer k-space data from a fully sampled reference image acquired immediately after the dynamic scan \[[@B45]\]. A phase difference image was generated for each of the dynamic time-points and the low spatial-frequency phase modulation was removed as described in \[[@B48]\]. An ROI was prescribed in the larger of the peroneal veins, and reference tissue was selected in an ROI immediately surrounding the peroneal vein. The phase accumulation was calculated from echoes at TE~1~ and TE~2~, with ΔTE = 3.21 ms and the difference between the intravascular and extravascular phase accumulation (∆*φ*) was computed. SvO~2~ was calculated from equation 2 \[[@B24]\]. Hematocrit of 0.45 was assumed for the healthy subjects, and in the PAD patients hematocrit was measured by blood draw. Washout time (time at which minimum SvO~2~ occurs), upslope, representing the rate of venous resaturation (maximum slope during recovery), and overshoot (peak SvO~2~ -- baseline SvO~2~) were recorded (Figure [2](#F2){ref-type="fig"}b).

*T*~*2*~\*: T~2~\* analysis was performed on keyhole-only data since high spatial resolution is not as critical (acquired matrix = reconstructed matrix = 96 × 24). T~2~\* was calculated by fitting a monoexponential function to magnitude SI from echoes TE~2~-TE~5~. Even though TE~1~ should have highest SNR, TE~1~ was not included in the monoexponential fitting because large switching gradients just prior to TE~1~ induced significant eddy current effects that would potentially confound T~2~\* quantification. For BOLD analysis, average SI in an ROI prescribed in the soleus muscle for each of the four echoes was fitted to a mono-exponential function to determine T~2~\* at each time-point. T~2~\* values were normalized to the baseline average and relative T~2~\*~min~, relative T~2~\*~max~, and time to peak (TTP~T2\*~) were determined (Figure [2](#F2){ref-type="fig"}c).

Statistical analysis
--------------------

The average and standard deviation of every time-point across all subjects and both sessions was calculated for PIVOT, PASL, and multi-echo GRE time-course data. Pearson's correlation coefficient was calculated to compare the time-courses measured with PIVOT and the standard methods.

For each key time-course-derived parameter, Wilcoxon signed-rank tests were used to assess whether statistically significant differences exist between PIVOT and the standard method. Specifically, PIVOT-derived perfusion parameters were compared to results obtained with PASL-only, and PIVOT-derived SvO~2~ or T~2~\* parameters were compared to results from the multi-echo GRE-only scan. Wilcoxon signed-rank tests were also used to determine whether significant differences exist between key parameters measured with PIVOT and PIVOT Repeat. Wilcoxon signed-rank tests were used in lieu of a standard paired Student's *t*-test as only five subjects were enrolled in the evaluation study and thus it cannot be assumed that the data are normally distributed. Statistical significance was set at p \< 0.05.

To assess both intra-session and inter-session repeatability, the average within-subject coefficient of variation (CV) was calculated. Specifically, to calculate intra-session repeatability, for each parameter the within-subject standard deviation across PIVOT and PIVOT Repeat from Visit 1 was averaged across subjects, then divided by the between-subject mean parameter value from Visit 1. The same analysis was performed for intra-session repeatability on data acquired during Visit 2. Similarly, to calculate inter-session repeatability, the within-subject standard deviation across all PIVOT scans from Visit 1 and Visit 2 (4 measurements per subject) was averaged across all subjects and divided by the between-subject mean parameter value from both visits.

In the PAD patients, all time-course parameters described above were calculated, but no statistical analyses were performed since patients included in this preliminary study have varying disease severity and the ischemia-reperfusion paradigm was slightly different. The purpose of including PAD patient data was for proof of principle and to explore differences that exist between patients and healthy subjects.

Results
=======

PIVOT evaluation in young healthy subjects
------------------------------------------

Example images are shown for a representative subject in Figure [3](#F3){ref-type="fig"}. High-resolution images corresponding to the PASL (isocenter) and multi-echo GRE slices (3 cm inferior) along with highlighted regions indicating the muscle or vein of interest are included in panels (a) and (b). Sample baseline and peak hyperemia perfusion maps are shown in (c) and (d), respectively. These images highlight the dramatic increase in perfusion that occurs in response to induced ischemia. The green box in (b) shows the full FOV of the multi-echo GRE. Because the FOV of the multi-echo GRE was only 96 × 96 mm, aliasing along the phase-encoding direction occurred in several subjects. In this subject, the tibialis anterior muscle has wrapped posteriorly, and part of the gastrocnemius muscle has wrapped anteriorly. This aliasing did not affect the quantification of SvO~2~, and wrapped regions were avoided when selecting the soleus ROI for T~2~\* measurement. Sample phase images used for SvO~2~ quantification at baseline and hyperemia (corresponding to the minimum SvO~2~, which occurs at the washout time) are shown in (e) and (f). Keyhole reconstruction was used for the phase images to achieve higher apparent in-plane spatial resolution (1 × 1 mm), which is necessary in order to resolve the veins. However, since spatial resolution is less critical for T~2~\* only data acquired every TR was used for analysis. Thus each image in (g) has in-plane resolution of 1 × 4 mm.

![**Example images from a representative young healthy subject.** High-resolution scout images located at isocenter **(a)** and 3 cm inferior **(b)**, corresponding to the PASL and multi-echo GRE slice locations, respectively. The soleus is indicated in red **(a)** and green **(b)**, and the blue arrow points to the peroneal vein. Perfusion images represent baseline **(c)** and peak hyperemic flow **(d)**. Phase images are shown for baseline **(e)** and the washout time **(f)**. Note the increased phase accrual in the three veins at washout time, corresponding to a decrease in SvO~2~. The blue arrow identifies the peroneal vein that was used for dynamic SvO~2~ analysis. Multi-echo GRE magnitude images for each of the echo times used to quantify T~2~\* are shown in **(g)**.](1532-429X-15-70-3){#F3}

Data for all healthy subjects were averaged to yield an average perfusion, SvO~2~, or T~2~\* time-course in order to investigate the correlation of the results between PIVOT and PASL-only or multi-echo GRE-only methods. For each parameter, average and standard deviation of the time-courses across all subjects is shown in Figure [4](#F4){ref-type="fig"}. Following cessation of arterial occlusion, the typical reactive hyperemia response is seen in each of the measured parameters. The time-course measured with PIVOT is in good agreement with PASL-only or multi-echo GRE-only-measured responses. The correlation coefficient between PIVOT and PASL average perfusion time-course is 0.99, and between PIVOT and multi-echo GRE average SvO~2~ and T~2~\* time-courses are 0.98 and 0.99, respectively.

![**Average time**-**course data measured with PIVOT and standard measurement methods. (a)** Average perfusion time-course across all young healthy subjects measured with PIVOT (red) and PASL (black). Average SvO~2~**(b)** and T~2~\* **(c)** time-courses measured with PIVOT (blue, green, respectively) and a multi-echo GRE (black). Error bars indicate standard deviation. Grey box indicates period of arterial occlusion.](1532-429X-15-70-4){#F4}

Average (standard deviation) of key time-course parameters from PIVOT and the standard measurement methods are shown in Table [1](#T1){ref-type="table"}. The Wilcoxon signed-rank tests did not detect statistically significant differences between PIVOT and PIVOT Repeat, or between PIVOT and the standard measurement method for any of the key time-course parameters (p \> 0.05). Table [2](#T2){ref-type="table"} summarizes the intra-session and inter-session repeatability measured with PIVOT.

###### 

**Means and standard deviations** (**in parentheses**) **of key time**-**course metrics measured with PIVOT and standard measurement methods in five young healthy subjects on two separate occasions**

                                                                             ***Visit 1***   ***Visit 2***                                            
  ------------------------------------------------------------------------- --------------- --------------- ------------- ------------- ------------- -------------
  ***Perfusion*** (***Standard Method*** = ***PASL***)                                                                                                
  PHF (mL/min/100g)                                                           34.8 (7.5)      34.5 (10.2)    37.9 (9.0)    39.2 (4.1)    38.3 (6.0)    37.6 (5.6)
  TTP (s)                                                                     19.6 (3.6)      18.0 (3.5)     17.2 (2.3)    18.4 (5.7)    17.2 (4.1)    17.6 (5.2)
  HFV (mL/100g)                                                               17.0 (5.3)      14.0 (5.0)     16.2 (5.6)    16.7 (5.4)    14.4 (1.9)    16.1 (2.3)
  Hyperemic duration (s)                                                      53.6 (15.7)     46.8 (13.8)    53.6 (10.4)   48.8 (14.9)   44.8 (10.3)   49.6 (14.2)
  ***SvO***~***2***~ (***Standard Method*** = ***multi***-***echo GRE***)                                                                             
  Washout time (s)                                                            11.6 (2.2)      10.0 (2.0)     10.4 (1.7)    12.4 (3.6)    11.2 (4.8)    10.0 (1.4)
  Upslope (%HbO~2~/s)                                                         0.83 (0.32)     1.08 (0.47)    1.21 (0.54)   1.14 (0.42)   0.91 (0.43)   1.13 (0.48)
  Overshoot (%HbO~2~)                                                         17.6 (7.5)      17.1 (6.1)     16.8 (7.1)    18.6 (6.5)    16.5 (7.6)    18.3 (5.0)
  ***T***~***2***~\* (***Standard Method*** = ***multi***-***echo GRE***)                                                                             
  Baseline T~2~\* (ms)                                                        23.4 (1.4)      22.5 (1.5)     23.1 (2.0)    22.0 (1.9)    21.7 (1.6)    22.2 (2.0)
  Relative T~2~\*~min~                                                        0.90 (0.04)     0.93 (0.03)    0.92 (0.01)   0.92 (0.03)   0.93 (0.04)   0.94 (0.02)
  Relative T~2~\*~max~                                                        1.09 (0.03)     1.13 (0.04)    1.16 (0.05)   1.14 (0.05)   1.15 (0.05)   1.18 (0.05)
  TTP~T2\*~ (s)                                                               34.0 (11.6)     29.2 (3.6)     26.8 (5.2)    28.4 (3.6)    24.8 (5.0)    28.4 (4.8)

No statistically significant differences were detected in any measured parameter.

###### 

**Summary of intra**-**session and inter**-**session repeatability for all time**-**course**-**derived metrics is presented as the within-subject coefficient of variation**

                            **Intra**-**session**   **Intra**-**session**   **Inter**-**session**
  ------------------------ ----------------------- ----------------------- -----------------------
  ***Perfusion***                                                          
  PHF (mL/min/100g)                 6.3%                    5.0%                    12.4%
  TTP (s)                           6.0%                    11.1%                   16.4%
  HFV (mL/100g)                     18.8%                   23.4%                   18.9%
  Hyperemic duration (s)            15.2%                   25.4%                   19.9%
  ***SvO***~***2***~                                                       
  Washout time (s)                  15.7%                  12.0 %                   18.9%
  Upslope (%HbO~2~/s)               26.2%                   15.8%                   37.3%
  Overshoot (%HbO~2~)               15.3%                   18.3%                   6.5%
  ***T***~***2***~\*                                                       
  Baseline T~2~\* (ms)              3.1%                    1.3%                    4.6%
  Relative T~2~\*~min~              2.4%                    0.9%                    1.8%
  Relative T~2~\*~max~              3.0%                    1.1%                    3.9%
  TTP~T2\*~ (s)                     17.9%                   9.6%                    19.9%

PIVOT in PAD patients
---------------------

Figure [5](#F5){ref-type="fig"} shows the reactive hyperemia time-courses for perfusion, SvO~2~, and T~2~\* measured with PIVOT in a single PAD patient and a representative young healthy subject. A summary of key time-course parameters measured in individual PAD patients is presented in Table [3](#T3){ref-type="table"} along with average values for young healthy subjects. The perfusion time-course data show that patients experienced a lower PHF, a delay in TTP, a prolonged hyperemic duration, and a greater HFV. The SvO~2~ response was also delayed and blunted; PAD patients exhibited a longer washout time, and reduced upslope and overshoot. T~2~\* data showed characteristic changes expected in patients with reduced endothelial function. PAD patients had higher T~2~\*~min~, even though the ischemic duration is 5 minutes instead of 3 minutes as in the healthy subjects. Patients' T~2~\*~max~ was lower and TTP~T2\*~ was delayed. These results are in agreement with previous findings measuring perfusion \[[@B17]\], SvO~2~\[[@B10],[@B25]\], or T~2~\* \[[@B26],[@B44]\] individually in PAD patients.

![**Time**-**courses measured with PIVOT for perfusion (a), SvO**~**2**~**(b), and T**~**2**~**\* (c) in one representative young healthy subjects and one PAD patient (PAD \#5 in Table**[2](#T2){ref-type="table"}**).** Light colored lines represent healthy subject, and dark colored lines represent PAD patient. Grey box indicates period of arterial occlusion. PAD patient exhibits a blunted and delayed hyperemic response for each of the measured parameters compared to the young healthy subject.](1532-429X-15-70-5){#F5}

###### 

PIVOT results in individual PAD patients and for the average of all young healthy subjects

                            **Healthy**   **PAD** \#**1**   **PAD** \#**2**   **PAD** \#**3**   **PAD** \#**4**   **PAD** \#**5**
  ------------------------ ------------- ----------------- ----------------- ----------------- ----------------- -----------------
  ABI                           N/A            0.41              0.52              0.68              0.72              0.74
  ***Perfusion***                                                                                                
  PHF (mL/min/100g)         37.0 (6.1)         26.9              22.0              31.3              29.9              37.3
  TTP (s)                   19.0 (4.5)          110               72                90                52                32
  HFV (mL/100g)             16.9 (5.1)         48.2              26.5              78.7              37.7              33.8
  Hyperemic duration (s)    51.2 (14.6)         182               124               240               110               108
  ***SvO***~***2***~                                                                                             
  Washout time (s)          12.2 (2.2)          48                50                22                36                22
  Upslope (%HbO~2~/s)        1.0 (0.6)         0.24              0.18              0.45              0.69              0.45
  Overshoot (%HbO~2~)       18.1 (6.5)         16.4              17.9              13.2              16.7              12.9
  ***T***~***2***~\*                                                                                             
  Baseline T~2~\* (ms)      22.6 (1.7)         22.2              22.4              21.6              20.4              20.0
  Relative T~2~\*~min~      0.91 (0.03)        0.93              0.94              0.92              0.95              0.94
  Relative T~2~\*~max~      1.11 (0.04)        1.04              1.04              1.11              1.04              1.12
  TTP~T2\*~ (s)             32.8 (8.8)          120               60                94                56                68

Discussion
==========

PIVOT repeatability
-------------------

The repeatability assessment comparing perfusion, SvO~2~, and T~2~\* metrics derived from the two successive PIVOT scans show some intra-session variability. This variability could be physiologic in nature or could be due to noise in the time-course data. Given the low average baseline signal standard deviation (perfusion: 1.6 mL/min/100g; SvO~2~: 1.5 %HbO~2~; T~2~\*: 0.5%) it is likely that intra-session variations of key measured parameters are outweighed by physiologic variability during separate ischemia-reperfusion episodes. In all cases there were no significant differences detected between time-course parameters measured with PIVOT and PIVOT Repeat (p\>0.05), suggesting that there was no training effect due to multiple periods of ischemia. This finding justifies the comparison of within-session PIVOT to PASL-only or to multi-echo GRE-only sequences, even though the data were acquired separately.

PIVOT effect on perfusion quantification
----------------------------------------

In comparing perfusion metrics measured with PIVOT to those measured with an otherwise identical PASL-only sequence, it is evident that the two measurements provide similar values of all perfusion time-course-derived metrics. Specifically, there were no significant differences between any of the key parameters measured with PIVOT or with PASL. This suggests that the multi-echo GRE interleave does not impact the quantification of perfusion.

Perfusion time-course metrics had expected results for longitudinal reproducibility. A CV of approximately 20% has been reported in previous studies \[[@B15],[@B49]\]. Perfusion varies physiologically with time of day \[[@B50]\], hydration level \[[@B51]\], and hormonal fluctuations \[[@B52]\] among other factors \[[@B53]\]. Care was taken to schedule Visits 1 and 2 at the same time, and all subjects were instructed to refrain from caffeine intake and vigorous activity for 12 hours prior. Yet even within a single scan there was variability in the hyperemic response from one ischemia-reperfusion episode to another, suggesting that these physiologic factors cannot be completely controlled. The time-course data averaged over all experiments and all healthy subjects showed good correlation in the shape and magnitude of the reactive hyperemia response, reflected by the high correlation coefficients. Thus not only were the key time-course-derived metrics not significantly different, but that the overall response was highly similar.

Peak hyperemic flow measured with either PIVOT or PASL was somewhat lower than previously reported values, where PHF was measured to be 50 ± 13 mL/min/100 g using the same SATIR perfusion preparation, but with a RARE readout \[[@B16]\]. PHF in the soleus in our study was lower, reaching only 37.0 ± 6.1 mL/min/100 g. This difference in perfusion could be attributed to the fact that Raynaud et al. quantified whole-leg perfusion \[[@B16]\], while individual muscle perfusion was calculated here. Additionally, care was taken to exclude vessels from the ROI, as their inclusion would increase measured perfusion. In another study by Proctor and colleagues, perfusion was measured in the calf of 64 men using strain gauge plethysmography \[[@B54]\], a technique considered to be a standard for limb perfusion measurement. Peak perfusion in the calf was found to be 35.1 ± 1.1 mL/min/100 g following a period of 10 minutes of ischemia. This work and that by Raynaud \[[@B16]\] and Proctor \[[@B54]\] report much lower PHF than a similar study by Wu et al. using continuous arterial spin labeling (CASL). In Wu's study, PHF in the soleus muscle was found to be 116 ± 57 mL/min/100 g \[[@B15]\], however the temporal resolution in CASL was limited to 16 seconds. Using an EPI readout, the magnitude signal over the course of an ischemia reperfusion paradigm varies substantially due to the BOLD effect. If the time course is not sampled with high enough temporal resolution, the changing signal intensity due to the BOLD effect may contaminate the quantification of perfusion \[[@B55]\]. The higher temporal resolution data acquired with SATIR can track the changes in signal intensity better and thus may be less susceptible to BOLD contamination, allowing more accurate quantification of perfusion.

Time to peak perfusion agreed with Raynaud's values \[[@B16]\], however it was much shorter than the TTP reported by Wu \[[@B15]\]. Again, this discrepancy between our work and that of Wu et al. could be due to the better temporal resolution of SATIR over CASL. The temporal resolution for PIVOT and SATIR was 2 seconds, while that of the CASL sequence employed in Wu's work was 16 s. The improvement in temporal resolution was in part due to the pulsed tagging scheme used in SATIR, in which arterial tagging takes only 8 ms instead of 2 seconds as in CASL.

Hyperemic flow volume quantified the total blood delivery during hyperemia, and along with the hyperemic duration may provide more qualitative measures of hyperemia. HFV in particular may be less sensitive to time-course noise compared to PHF and TTP. PHF and TTP are determined based on a single data-point, whereas HFV is the total integrated area. The values we reported for HFV and hyperemic duration were lower and shorter than those reported by Wu, et al. \[[@B15]\], which is not surprising since our measured PHF and TTP are lower and shorter as well.

PIVOT effect on SvO~2~ quantification
-------------------------------------

High spatial resolution is necessary to measure the phase in the vein; therefore the keyhole multi-echo GRE data was supplemented with outer k-space data from a fully-phase-encoded reference scan that was run at the end of the dynamic acquisition. Langham et al. have previously shown that keyhole reconstruction provides accurate SvO~2~ results with high temporal resolution during reactive hyperemia in the femoral vein \[[@B56]\].

No significant differences were detected between time-course metrics measured with PIVOT or with the multi-echo GRE. While inter-session variability was present, it was comparable to the intra-session variability measured between PIVOT and PIVOT Repeat on the same visit. Average washout time was slightly lower than previously reported in the femoral vein of young healthy subjects (17 ± 7 s), but upslope and overshoot were in agreement with prior results \[[@B10]\]. The lower washout time could be explained by the fact that the tourniquet system used in this study deflated much more quickly than that used in \[[@B10]\]. The resulting decrease in the resistance to arterial flow could potentially shorten the washout time. Another potential reason that washout time differs is that we investigated SvO~2~ in the peroneal vein, as opposed to the more superior femoral vein. Thus not only does the peroneal vein collect from a smaller volume of muscle, but the distance between the capillary bed and peroneal vein was also smaller. Overall, key parameters measured with PIVOT agree with multi-echo GRE-derived data, suggesting that inclusion of the PASL interleave does not impact quantification of SvO~2~.

PIVOT effect on T~2~\* quantification
-------------------------------------

In both PIVOT and multi-echo GRE T~2~\* data, the signal intensity in the ROI was first averaged then fit to a mono-exponential function. The fitting of average signal intensity was nearly perfect with an overall average R^2^ for all T~2~\* fits of 0.999.

During the period of arterial occlusion, relative T~2~\* was found to decrease as the deoxyhemoglobin concentration in the capillary bed increases. Following cuff release, hyperemic arterial inflow replenishes blood in the capillary bed, bringing oxygenated arterial blood in and moving desaturated blood into the large draining veins. Relative T~2~\* increased during reactive hyperemia due to the increase in perfusion and the decrease in deoxyhemoglobin in the capillary bed. Even though perfusion and T~2~\* were measured at separate slice locations, they both represent changes that occur in the soleus muscle. TTP~T2\*~ was longer than perfusion TTP, suggesting that the increase in oxygen concentration at the level of the capillary bed lasted longer than the increase in microvascular flow. This finding is in agreement with a prior study investigating the combined measurement of perfusion and BOLD during reactive hyperemia \[[@B28]\]. Duteil et al. suggest that because the brief period of arterial occlusion does not cause significant oxygen debt in muscle (as shown by \[[@B57]\]), the muscle's demand for oxygen remains unchanged and thus the increase in perfusion results in a decrease of oxygen extraction, causing the BOLD signal to increase \[[@B28]\]. The decrease in oxygen extraction also physiologically manifests as the SvO~2~ overshoot.

The measured values are consistent with previous literature reported values for baseline T~2~\* \[[@B58]\], relative T~2~\*~min~\[[@B44]\], T~2~\*~max~\[[@B26],[@B59]\], and TTP~T2\*~\[[@B26]\]. Comparisons between PIVOT and multi-echo GRE key time-course parameters yielded no significant differences, and the T~2~\* time-course data measured with PIVOT and multi-echo GRE were highly correlated (Pearson's r = 0.99). These results indicate that T~2~\* quantification in a downstream slice with PIVOT is not affected by the PASL interleave.

Considerations for applying PIVOT in PAD patient studies
--------------------------------------------------------

Statistical comparisons between PAD patients and young healthy subjects were not made because the ischemic duration differed in the two cohorts. As repeated periods of arterial occlusion were used to compare PIVOT to standard measurement methods in healthy subjects, a shortened ischemic duration was used, allowing enough time for the four scans to be performed during one hour of scanning. PAD patients included in this preliminary evaluation had varying disease severity, represented by the diverse ABIs. A five-minute period of arterial occlusion was employed in PAD patients to ensure the maximal hyperemic stimulus. The PAD patient data were, however, included to explore the range of values that exist between states of health and disease. In agreement with the results of Wu et al., PAD patients exhibited a decrease in PHF and an increase in TTP \[[@B17]\]. SvO~2~ data showed a blunted and delayed response, in agreement with Langham et al. \[[@B10],[@B25]\]. T~2~\* data showed the characteristic alterations during the period of ischemia \[[@B44]\] and reactive hyperemia \[[@B26]\].

Quantification of multiple parameters may improve diagnosis and enhance power for detection of the response to therapeutic intervention. The traditional marker of disease severity in PAD is the ankle-brachial index (ABI), which is the ratio of systolic blood pressures measured at the level of the ankle and in the brachial artery. The ABI primarily represents occlusions and stenoses on the macrovascular level. Previous studies have shown that physiologic improvements such as increased peak walking time do not correlate with clinically significant changes in ABI \[[@B60],[@B61]\]. PIVOT provides a measure of microvascular function, thus may be more sensitive to early treatment effects. By measuring many parameters, PIVOT will provide insight into the relationship between impairments in perfusion, SvO~2~, and T~2~\*.

In this study we showed that no major measurement bias in key time-course parameters was introduced by using PIVOT instead of the standard individual measurement methods. However, it should be noted that the small sample size affects the power to detect such a bias. Even though no measurement bias was detected, the precision and thus statistical power of PIVOT-derived measures was limited by physiologic variability, which cannot be completely controlled. In order to use this method to assess disease presence or monitor a treatment effect, the study must be well designed, controlling for factors that are known to affect perfusion and the hyperemic response \[[@B50]-[@B53]\].

The preliminary PAD patient data showed that for many of the key time-course parameters there was a relatively wide range of values that exist between states of health and disease. A recent study performed at 1.5T showed relatively poor repeatability of BOLD measurements with the exception of TTP~T2\*~ during reactive hyperemia in both healthy subjects and PAD patients \[[@B49]\]. In our study a lower inter-session CV, and hence better repeatability, was found for several key T~2~\* parameters in healthy subjects. The improvement in repeatability may be due to the higher field strength, which confers increased signal to noise ratio and greater BOLD signal contrast. A longitudinal study will be necessary to determine the repeatability of PIVOT measures in PAD patients. Additionally vascular reactivity decreases with age \[[@B25]\], therefore it will be important to compare PIVOT results obtained for PAD patients to age-matched healthy controls to assess the impact of age on PIVOT-derived measures of microvascular function.

Conclusions
===========

In summary, we have introduced a quantitative MR method that measures perfusion, SvO~2~, and T~2~\* simultaneously, thereby allowing a comprehensive assessment of the functional integrity of the peripheral microvasculature during a single ischemia-reperfusion paradigm. The added value of the proposed approach will require rigorous evaluation in cohorts of patients with impaired peripheral circulation in comparison to their healthy peers. In the future PIVOT could possibly serve as a means to monitor disease progression and effectiveness of intervention.
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